Quick Overview: Just about the hottest thing in longevity science right now is partial reprogramming - using Yamanaka factors to rewind the ... Today I am on the road and have come to visit Daniel Ives, CEO of What if reversing cellular aging could be achieved by overexpressing just a

Inside Shift Bioscience S Single - Detailed Overview & Context

Just about the hottest thing in longevity science right now is partial reprogramming - using Yamanaka factors to rewind the ... Today I am on the road and have come to visit Daniel Ives, CEO of What if reversing cellular aging could be achieved by overexpressing just a Talk Title: A path to safe cellular rejuvenation Daniel Ives, CEO and Founder of A Metabesity 2021 Emerging Company Showcase presentation on In this week's episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks, spoke with ...

Core to the clinical-stage biopharma Life I've got this slide which I I stole from from Yuri Dean actually at life On this episode of Cell & Gene: The Podcast, Host Erin Harris talks to Life In this episode of Longevity Papers, we critically analyze a groundbreaking new paper for biotech researchers and longevity ... Moderator: Adrian Toutoungi, Taylor Wessing Panellists: Janette Thomas, Five Alarm Bio Ltd, Panteli Theocharous, PPD, Daniel ... What if aging could be slowed — or even reversed? In this video, we explore a groundbreaking age-reversal clinical trial ...

In this talk, Sebastian Brunemeier discusses building and investing in longevity biotech, providing an overview of the biopharma ... Greg Schmergel and Keshav Singh don't claim to have found the Fountain of Youth. But by founding Yuva

Photo Gallery

Inside Shift Bioscience’s single-gene rejuvenation breakthrough — Exclusive with CEO Daniel Ives
Inside a Longevity Biotech Company - Shift Bioscience (Cellular Reprogramming)
one gene for cell rejuvenation?
Investing in the Age of Longevity 2021 | Shift Bioscience | Daniel Ives
Targeting Safe Cellular Rejuvenation for Longevity - Shift Bioscience
Investing in the Age of Longevity 2024 – Daniel Ives – Shift Bioscience
Metabesity 2021: Shift Bioscience
Finding genes at scale for age reversal - Shift Bio CEO Daniel Ives
Drug Target Discovery for Cellular Rejuvenation by ‘Driver’ Clocks  | Daniel Ives, Shift Bioscience
The Biology of Aging: Cellular Rejuvenation with Life Biosciences’ Dr. Sharon Rosenzweig-Lipson
Milner Pitch Day 2025 - Shift Bioscience Pitch
Bio & The Business Of Aging with Life Biosciences' Jerry McLaughlin
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored